File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Aspirin and risk of multiple myeloma in adults: A systematic review and meta-analysis

TitleAspirin and risk of multiple myeloma in adults: A systematic review and meta-analysis
Authors
KeywordsAnalgesics
Meta-analysis
Multiple myeloma
Aspirin
Neoplasms
Issue Date2017
Citation
Leukemia Research Reports, 2017, v. 7, p. 23-28 How to Cite?
AbstractMultiple myeloma is a relatively uncommon plasma cell malignancy. Preclinical and clinical studies have suggested that aspirin might modify the risk of multiple myeloma. We performed a systematic review and meta-analysis of studies to examine the association between regular aspirin use and risk of multiple myeloma. Five observational studies including 332,660 adults were evaluated. The pooled estimate had a hazard ratio of 0.90 (95% confidence interval =0.58−1.39; P=0.638). Odds ratios from the two case-control studies were similar. The findings demonstrated that there was no significant association between aspirin use and the risk of multiple myeloma.
Persistent Identifierhttp://hdl.handle.net/10722/303512
ISSN
2023 Impact Factor: 0.7
2023 SCImago Journal Rankings: 0.299
PubMed Central ID

 

DC FieldValueLanguage
dc.contributor.authorLee, Shing Fung-
dc.contributor.authorNg, Ting Ying-
dc.contributor.authorWong, Frank Chi Sing-
dc.contributor.authorTung, Stewart Yuk-
dc.date.accessioned2021-09-15T08:25:28Z-
dc.date.available2021-09-15T08:25:28Z-
dc.date.issued2017-
dc.identifier.citationLeukemia Research Reports, 2017, v. 7, p. 23-28-
dc.identifier.issn2213-0489-
dc.identifier.urihttp://hdl.handle.net/10722/303512-
dc.description.abstractMultiple myeloma is a relatively uncommon plasma cell malignancy. Preclinical and clinical studies have suggested that aspirin might modify the risk of multiple myeloma. We performed a systematic review and meta-analysis of studies to examine the association between regular aspirin use and risk of multiple myeloma. Five observational studies including 332,660 adults were evaluated. The pooled estimate had a hazard ratio of 0.90 (95% confidence interval =0.58−1.39; P=0.638). Odds ratios from the two case-control studies were similar. The findings demonstrated that there was no significant association between aspirin use and the risk of multiple myeloma.-
dc.languageeng-
dc.relation.ispartofLeukemia Research Reports-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectAnalgesics-
dc.subjectMeta-analysis-
dc.subjectMultiple myeloma-
dc.subjectAspirin-
dc.subjectNeoplasms-
dc.titleAspirin and risk of multiple myeloma in adults: A systematic review and meta-analysis-
dc.typeArticle-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1016/j.lrr.2017.02.002-
dc.identifier.pmid28331798-
dc.identifier.pmcidPMC5348598-
dc.identifier.scopuseid_2-s2.0-85014158678-
dc.identifier.volume7-
dc.identifier.spage23-
dc.identifier.epage28-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats